The role that benazepril decrease BP may be related with NO.
苯那普利的降压作用可能与NO有关。
Objective: to explore the clinical effect of benazepril to treat diabetic nephropathy.
目的：探讨贝那普利治疗糖尿病肾病的临床效果。
Medications in this category include benazepril (Lotensin), captopril (Capoten) and enalapril (Vasotec).
这类药物包括贝那普利(洛汀新)、卡托普利(开博通)、依那普利等。
There was no difference between benazepril postconditioning group and preconditioning group (P>0.05).
苯那普利后处理组和预处理组相比较，差异无统计学意义（P>0.05）。
OBJECTIVE To explore the absorption mechanism of benazepril hydrochloride from various intestinal segments.
目的：研究盐酸贝那普利在大鼠小肠的吸收情况。
Aim... to compare the reverse effect of Captopril with Benazepril on hypertensive left ventricular hypertrophy.
目的探讨卡托普利与苯那普利治疗高血压及逆转左室肥厚的作用。
Conclusion: in equal dose consistency, JTTM was superior to Benazepril on the inhibition the proliferation of MC.
结论：在等效剂量浓度下，降糖通脉片对MC的抑制作用优于苯那普利。
Benazepril and valsartan can decreased the degree of atrial fibrosis and remodeling of Gap junction connexin effectively.
贝那普利及缬沙坦可有效减轻心房纤维化和心肌缝隙连接蛋白的重构。
Objective: To observe the efficacy of using benazepril to heal hypertension complicated with 2-type diabetic nephropathy.
目的：观察苯那普利治疗高血压合并2型糖尿病肾病的疗效。
It is recommended to monitor plasma potassium levels when using benazepril in combination with a potassium sparing diuretic.
建议监测血钾水平时，结合使用了利尿剂钾苯那普利。
OBJECTIVE: To discuss the manifestation characteristics and regularities of adverse drug reactions (ADR) induced by benazepril.
前言：目的：探讨贝那普利不良反应发生的特点及规律。
Objective: To study the effects of benazepril(ACEI) on renal functional reserve(RFR) of patients with essential hypertension (EH).
目的：研究血管紧张素转化酶抑制剂（ACEI）苯那普利对原发性高血压（EH）患者肾功能储备（RFR）的影响。
To investigate the effect of benazepril on expression of cyclin kinase inhibitor P21 CIP1 protein in renal tissue of diabetic rats.
目的：探讨苯那普利对糖尿病大鼠肾组织细胞周期蛋白激酶抑制剂p 21 CIP1蛋白表达的影响。
Objective to explore the predict factors of antihypertensive efficacy response to Benazepril treatment in essential hypertension patients.
目的探讨原发性高血压患者贝那普利降压疗效的预测指标。
Results Benazepril could decreased elevated serum creatinine lever, relative kidney weight and ACE activities in diabetic rats renal cortex.
结果苯那普利能降低糖尿病大鼠血肌酐、相对肾重及肾皮质a C e活性。
Objective to explore the influential factors of antihypertensive efficacy response to Benazepril treatment in essential hypertension patients.
目的为了探讨原发性高血压患者苯那普利降压疗效的影响因素。
Objective It is to observe the therapeutic effect of Xiaoke Baoshen Decoction(XBD) combined with Benazepril on early diabetic nephropathy(EDN).
目的观察中药消渴保肾汤与贝那普利联合治疗早期糖尿病肾病的疗效。
Objective: To explore the reverse effects of valsartan and benazepril on left ventricular hypertrophy (LVH) in spontaneously hypertensive rats (SHR).
目的：比较缬沙坦和苯那普利逆转左心室肥厚（LVH）的效应。
Conclusion: the treatment with carvedilol combined with Benazepril to treat the CHF patients is better the combined with amlodipine, the prognosis is better.
结论：卡维地洛联合贝那普利治疗慢性充血性心力衰竭疗效优于联合氨氯地平，预后较好。
Objective to observe the protective effects on diabetic nephropathy (DN) rats by Xueshuantong injection combined with benazepril and to explore its therapeutic mechanism.
目的观察血栓通注射液联合贝那普利对糖尿病肾病(DN)大鼠肾脏的保护作用，探讨其作用机制。
Results Benazepril reduced left ventricular weight, decreased blood pressure, reduced hyperplasia of collagen and calcineurin activation, and make microstructure stable as well.
结果苯那普利可以减轻左心室重量，降低血压，减少胶原的增生，并使心肌中钙调神经磷酸酶活性降低，微结构稳定。
To explore the intensity of inhibitory function of Shenkang injection (SKI), a Chinese herbal recipe, and benazepril on the proliferation of human glomerular mesangial cell (MC).
目的：探讨肾康注射液与苯那普利对人肾小球系膜细胞（MC）增殖的不同抑制作用强度。
CONCLUSION: Imidapril and benazepril are both similarly effective in the reduction of the peripheral blood pressure and the central blood pressure in the treatment of hypertension.
结论：咪达普利和贝那普利降低外周动脉压和中心动脉压一样有效。
Objective To observe the effect of benazepril, an angiotensin converting enzyme inhibitor (ACEI) , on reducing proteinuria in a nephrotic young rat model of with massive proteinuria.
目的观察血管紧张素转换酶抑制剂苯那普利减轻幼龄肾病大鼠蛋白尿的作用。
Objective: To observe the clinical efficacy of insulin glargine, acarbose and benazepril in the combined treatment of early-stage diabetic nephropathy(DN) in type 2 diabetes mellitus(T2DM).
目的：观察甘精胰岛素、阿卡波糖与盐酸贝那普利联合治疗2型糖尿病早期肾病的临床疗效。
Objective: To observe the clinical efficacy of insulin glargine, acarbose and benazepril in the combined treatment of early-stage diabetic nephropathy(DN) in type 2 diabetes mellitus(T2DM).
目的：观察甘精胰岛素、阿卡波糖与盐酸贝那普利联合治疗2型糖尿病早期肾病的临床疗效。
应用推荐